NEW YORK (GenomeWeb) – Illumina reported after the close of the market on Tuesday that its first quarter 2017 revenues rose 5 percent over the first quarter of 2016.

For the three months ended April 2, Illumina recognized $598.0 million, up from $572.0 million in Q1 2016, beating analysts' average estimate of $590.8 million.

Illumina's total revenue included $491.0 million in product revenue, up from $483.0 million a year earlier, and $107.0 million in service and other revenue, up from $89.0 million in Q1 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
31
Sponsored by
Roche

This webinar highlights the use of single-cell genomics to identify distinct cell types and states associated with enhanced immunity.